Misra Anoop, Joshi Shashank, Mithal Ambrish
Diabetes Foundation India, New Delhi, India; Fortis CDOC Center of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), New Delhi, India.
Lilavati Hospital, Mumbai, India.
Diabetes Metab Syndr. 2025 May;19(5):103250. doi: 10.1016/j.dsx.2025.103250. Epub 2025 Jun 4.
To critically evaluate the historical context, diagnostic ambiguity, epidemiological relevance, and recent proposals to reclassify malnutrition-related diabetes mellitus (MRDM) amid changing nutritional landscapes and existing metabolic data.
This review synthesizes data from early clinical reports, WHO documents, epidemiological studies, and recent literature on malnutrition and diabetes. Emphasis is placed on diagnostic inconsistencies, the overuse of low BMI as a surrogate for malnutrition, and evolving nutrition trends in India and low- and middle-income countries (LMICs).
MRDM was initially associated with protein-energy malnutrition, low BMI, and insulin-requiring but ketosis-resistant diabetes. However, overlap with other diabetes types, especially autoimmune forms, has raised doubts about its distinct identity. Low BMI is an unreliable proxy for malnutrition in often constitutionally lean populations in LMICs. A 2022 study suggested insulin secretory defects in MRDM, but was limited by small, male-only samples and lack of follow-up. Proposals to classify MRDM as "type 5 diabetes" are questionable, as types 3 and 4 lack formal recognition. Moreover, declining undernutrition rates in LMICs further diminish MRDM's current relevance. Emerging evidence also indicates malnutrition may be more often a consequence than a cause of diabetes.
Given its heterogeneity, diagnostic uncertainty, and diminishing epidemiological significance, reclassifying MRDM as a distinct type of diabetes ("type 5 diabetes") is presently unwarranted. Future classification efforts should prioritize data-driven subtypes with clear therapeutic and prognostic implications, rather than reviving outdated constructs with limited contemporary utility.
在营养状况不断变化和现有代谢数据的背景下,批判性地评估历史背景、诊断模糊性、流行病学相关性以及最近关于重新分类营养不良相关糖尿病(MRDM)的提议。
本综述综合了早期临床报告、世界卫生组织文件、流行病学研究以及近期关于营养不良和糖尿病的文献。重点关注诊断不一致性、将低体重指数过度用作营养不良替代指标的情况,以及印度和低收入及中等收入国家(LMICs)不断变化的营养趋势。
MRDM最初与蛋白质 - 能量营养不良、低体重指数以及需要胰岛素但抗酮症的糖尿病相关。然而,与其他糖尿病类型(尤其是自身免疫形式)的重叠引发了对其独特性的质疑。在LMICs中,通常体型偏瘦的人群中,低体重指数是营养不良的不可靠替代指标。2022年的一项研究表明MRDM存在胰岛素分泌缺陷,但受限于样本量小、仅为男性样本且缺乏随访。将MRDM分类为“5型糖尿病”的提议存在问题,因为3型和4型糖尿病缺乏正式认可。此外,LMICs中营养不良率的下降进一步削弱了MRDM目前的相关性。新出现的证据还表明,营养不良可能更多是糖尿病的后果而非原因。
鉴于其异质性、诊断不确定性以及流行病学意义的减弱,目前将MRDM重新分类为一种独特的糖尿病类型(“5型糖尿病”)是没有必要的。未来的分类工作应优先考虑具有明确治疗和预后意义的数据驱动亚型,而不是恢复当代效用有限的过时概念。